Katherine Marriott News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rushcliffe Borough Council holds drop-in sessions, including at Bingham, Cotgrave and Orston, for help with voter ID forms

Drop-in sessions are to take place to help residents get the necessary photo ID and documentation to vote in person at the up-coming local elections.

United kingdomKatherine marriottRushcliffe borough councilCotgrave leisure centreCustomer serviceBingham arena leisure centreRuddington parish councilCustomer servicesVoter authority certificateEdwalton golf clubUnited kingdom governmentAge standards schemeVoter authorityBorough councilWellin laneChapel lane

Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally Bioavailab

- Collaboration with Xontogeny provides funding and key advisory support for early development -MALVERN, Pa. (BUSINESS WIRE) #Cardiovascular Shifa Biomedical Corporation (Shifa), a drug discovery company developing an oral small molecule PCSK9/low density lipoprotein-cholesterol receptor (LDLR) antagonist, P-21,.

United statesSherin abdel meguidKatherine marriottSherins abdel meguidKatie gallagherShaker mousaGianna hoffman lucaChris garabedianFred calloriNabil elshourbagyLavoie health scienceBiomedical corporation shifaAlbany college of pharmacyShifa biomedical corporationHealth sciencesCardiovascular shifa biomedical corporation

Nephraegis Therapeutics Launches with Seed Financing to Develop Small Molecules to Prevent and Treat Acute Kidney Injury (AKI)

Nephraegis Therapeutics Launches with Seed Financing to Develop Small Molecules to Prevent and Treat Acute Kidney Injury (AKI)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKatherine marriottBryan coxBryanf coxKatie gallagherJim stolzenbachDave schodinBen askewRichardb marshakRichard marshakChris garabedianFred calloriLavoie health sciencePartner of researchLegal affairsNephraegis therapeutics inc